Recon: Moderna plans to start Phase 3 coronavirus vaccine study on 27 July; Roche, Blueprint partner on targeted cancer drug

• Vaccine-makers’ ‘no profit’ pledge stirs doubts in Congress (Politico)
• Moderna will begin late-stage coronavirus vaccine trial on July 27 (CNBC) (Reuters)
• US COVID-19 vaccine program to start manufacturing by late summer, says official (Reuters) (Endpoints) (CNBC)
• Hospitals Stock Up on Covid-19 Drugs to Prepare for Second Wave in Fall (WSJ)
• Blueprint Medicines partners with Roche to develop and sell genetically targeted cancer drug (STAT)
• FDA rejects Verrica’s skin warts pitch, a month after flagging application ‘deficiencies’ (Endpoints)
• Ohio sues Express Scripts for ‘egregiously’ overcharging for medicines (STAT)

• Global vaccine plan may allow rich countries to buy more (AP)
• Covid Shot Derived From Tobacco-Like Plant Tested in Humans (Bloomberg)
• Pharmas restart drug trials after pandemic-related declines, Medidata finds (Reuters)
• Lupin shuts manufacturing drug plant after 17 employees test positive for Covid-19 (Economic Times)
• Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst (Fierce)
• Pharma trade group scolds Gilead again for misleading information about a rival HIV drug (STAT)
• Cytokinetics nabs Chinese partner, up to $450M as CV becomes company focus (Endpoints)
• European Parliament backs WHO effort to create a Covid-19 technology access pool (STAT)
• NICE links with Colombia’s Institute of Health Technology Assessment (PharmaTimes)

• Immunity to the coronavirus may last only a few months, UK study finds (CNBC)
• Mulvaney calls U.S. coronavirus testing abilities 'inexcusable,' breaking from Trump (Politico)
• TimesFauci says US local public healthcare is ‘in tatters’ (Financial Times)
• Coronavirus Sparks New Interest In Using Ultraviolet Light To Disinfect Indoor Air (NPR)
• 3M partners with MIT researchers to develop U.S.-backed rapid coronavirus antigen test (CNBC)
• Joined-Up EU Approach Is Key To Continuing COVID-19 Fight (Pink Sheet)
• AstraZeneca taps IQVIA to 'warp speed' its US pandemic vaccine research (Fierce)
• Coronavirus (COVID-19) Update: Daily Roundup July 13, 2020 (FDA)

• Biotech Properties Draw Billions of Dollars as Other Real Estate Languishes (WSJ)
• Sanofi and MD Anderson team up to accelerate cancer drug testing (STAT) (Endpoints)
• Biogen, Eisai take Alzheimer’s candidate BAN2401 into phase 3 (PMLive)
• Generic Drug User Fee Program Sees First-Ever Fee Spending Decrease, FTE Decline (Pink Sheet)
• Massachusetts biotech Revitope scores first collaboration thanks to dual-engaging T cell platform (Endpoints)
• Billions of dollars worth of SPACs are riding on the biotech IPO boom (Endpoints)
• Junshi taps Revitope for next-gen anticancer bispecifics (Fierce)
• Digital cancer pathology player Paige adds investments from Goldman Sachs, others (Fierce)
• US FDA Advisory Cmte. To Evaluate Terlipressin's Clinical Outcomes, Risk Of Respiratory Failure (Pink Sheet)
• Why pay $4B for a steady diet of disappointment? Porges turns thumbs down on Alexion’s M&A strategy, offers some pointers (Endpoints)
• A neoantigen pioneer says its tech is working great. So what wrecked the share price? (Endpoints)
• J&J nabs new OK for IL-23 drug Tremfya; Merck KGaA spinout ups Series A tally to €20.1M (Endpoints)

• Edwards to pay Abbott $468M to settle mitral, tricuspid repair device patent disputes (MedtechDive)
• Quest Q2 better than feared, as demand surges for COVID-19 diagnostics (MedtechDive)
• Shareholder challenges Thermo Fisher's $11.5B deal to buy Qiagen (MedtechDive) (Fierce)
• Abbott lays out plan for US study of FreeStyle Libre 3 (MedtechDive)
• An insider's look at how GM, Ventec ramped up ventilator production amid COVID-19 (MedtechDive)
• QSR Author Kim Trautman: FDA Should Change Name Of New Quality System Reg (And Other Thoughts) (MedtechInsight)
• Industry Fears Disruption For EU Medtech Market Surveillance System (MedtechInsight)
• US House Panel Votes For 5.8% Cut In FDA Device Center’s 2021 Budget Authority, Seeks COVID-19 Review (MedtechInsight)

• Electronic Submissions; Data Standards; Support for Standard for the Exchange of Nonclinical Data (Federal Register)
• New York Woman Sentenced for Selling Abortion-Inducing Pills Illegally Smuggled Into US (FDA)
• 3rd Circ. Mulling FTC-AbbVie Pause Till High Court Acts (Law360)
• 5 Compliance Lessons From Novartis' FCPA Settlement (Law360)
• Lilly Bars Contract Pharmacies From 340B Discounts Despite HRSA Guidance (Pink Sheet)
• Judge waives requirement for in-person visit to get abortion pill during pandemic (The Hill)
• Mallinckrodt Aims To Nix Medicaid FCA Suit Over Acthar Gel (Law360)